NAMS

NewAmsterdam Pharma Company N.V.

Price

$21.80

return (12m)

-18.34%

p/e

-10.30

p/bv

4.23

DIVIDEND YIELD

0.00%

NAMS price

NewAmsterdam Pharma Company N.V.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NAMS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-21.80%

3 months

-26.94%

1 year

-18.34%

2 years

35.71%

5 years

121.27%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NAMS

Valuation

P/E

-10.30

Sector 7.84

Industry 7.84

P/BV

4.23

Sector 1.84

Industry 1.84

P/Revenue (PSR)

375.26

Sector 1.78

Industry 1.78

EV/EBITDA

-31.45

Sector -57.74

Industry -57.74

EV/EBIT

-31.42

Sector -289.61

Industry -289.61

P/EBITDA

-10.94

Sector -9.38

Industry -9.38

P/EBIT

-10.93

Sector -9.71

Industry -9.71

P/Total Assets

3.79

Sector 0.86

Industry 0.86

P/Net Current Assets

4.56

Sector -2.04

Industry -2.04

P/Working Capital

4.56

Sector -4,847.72

Industry -4,847.72

EPS

-2.10

Sector 0.73

Industry 0.73

BVPS

5.12

Sector 9.89

Industry 9.89

Efficiency

Gross Margin

100.00%

Sector 35.14%

Industry 35.14%

EBITDA Margin

-1,751.01%

Sector 7.88%

Industry 7.88%

EBIT Margin

-1,752.61%

Sector -7.02%

Industry -7.02%

Operating Margin

-100.00%

Sector 4.32%

Industry 4.32%

Net Profit Margins

-100.00%

Sector 2.76%

Industry 2.76%

Asset Turnover

0.01

Sector 0.11

Industry 0.11

Profitability

ROE

-41.10%

Sector 2.49%

Industry 2.49%

ROA

-36.84%

Sector -0.64%

Industry -0.64%

ROIC

-216.94%

Sector -117.48%

Industry -117.48%

Dividends

Dividend yield

0.00%

Sector 0.50%

Industry 0.50%

Payout

Sector 9.69%

Industry 9.69%

Debt

Current Ratio

9.03

Sector 1.46

Industry 1.46

Net Debt / EBITDA

9.78

Sector -20.28

Industry -20.28

Net Debt / EBIT

9.77

Sector -165,634,871.06

Industry -165,634,871.06

Net Debt / Equity

-1.00

Sector -0.77

Industry -0.77

Gross Debt / Equity

0.00

Sector 0.06

Industry 0.06

Equity/Assets

0.90

Sector 0.43

Industry 0.43

Liabilities/Assets

0.10

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals NAMS

DRAG THE FRAME TO SEE MORE DATA

NAMS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Company N.V.

Average Investor10 user rating

4.0 (3 people)

United States

- year

Founded:

2022

Time since IPO - 4 years

100

Employees

NewAmsterdam Pharma Company N.V. (United States) is listed on the Nasdaq and has a market capitalization of $2.67 billion, with shareholders equity totaling $631.42 million.

The company employs approximately 100 people and operates in the Others sector, within the Others industry.

Over the past 12 months, NewAmsterdam Pharma Company N.V. reported $7.12 million in revenue, generating net income of $-259.50 million.

Key financial metrics include a P/E ratio of -10.30, a price-to-book (P/B) ratio of 4.23, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NAMS.

Market cap

$2.67 billion

Net worth

$631.42 million

$631,422,000.00

Assets

$704.45 million

$704,452,000.00

Total Shares Outstanding

123.37 million

123,370,000

Average Daily Trading Volume

$1.15 million

$1,150,190.00

Sector

Others

Industry

Others

NAMS

NAMS revenue and profits

Financial Results NAMS

DRAG THE FRAME TO SEE MORE DATA

NAMS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$374.03 14,72% (12M)

P/E

22.68

2.39%

ROE

14.27%

P/BV

3.24

SHEL - Shell PLC ADR

$94.75 40,21% (12M)

P/E

10.29

3.09%

ROE

14.29%

P/BV

1.47

STLA - Stellantis NV

$4.82 --51,25% (12M)

P/E

-0.62

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$307.93 6,98% (12M)

P/E

23.46

0.75%

ROE

81.08%

P/BV

19.02

ALIZY - Allianz SE ADR

$50.57 --9,44% (12M)

P/E

14.13

2.65%

ROE

17.89%

P/BV

2.53

TTE - TotalEnergies SE ADR

$90.89 62,49% (12M)

P/E

7.35

4.43%

ROE

21.42%

P/BV

1.57

NSRGY - Nestle SA ADR

$92.61 5,71% (12M)

P/E

11.41

4.22%

ROE

58.05%

P/BV

6.62

ELV - Elevance Health Inc

$407.90 33,34% (12M)

P/E

20.44

1.66%

ROE

9.84%

P/BV

2.01